The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTanfield Regulatory News (TAN)

Share Price Information for Tanfield (TAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.76
Bid: 3.60
Ask: 3.92
Change: 0.00 (0.00%)
Spread: 0.32 (8.889%)
Open: 3.76
High: 0.00
Low: 0.00
Prev. Close: 3.76
TAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Subscription Update

3 Mar 2022 12:56

RNS Number : 5580D
Tanfield Group PLC
03 March 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain

 

 

Tanfield Group Plc

("Tanfield" or the "Company")

 

Loan Subscription Update

 

 

The Board of Tanfield (the "Board") is pleased to update the market with respect to additional loans put in place to fund the Company's ongoing legal proceedings in relation to its investment in Snorkel International Holdings LLC ("Snorkel"), the aerial work platform business, and other day to day costs.

 

Investment Background

 

· Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme Manufacturing LLC ("Xtreme") (the "Contemplated Transaction"), a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

· The Snorkel investment is valued at £19.1m. The outcome of the US and UK Proceedings referenced below could have an impact on this valuation.

 

· On 22 October 2019, the Company announced that it had received a Summons and Complaint, filed in Nevada (the "US Proceedings") by subsidiaries of Xtreme, relating to the Contemplated Transaction.

 

· On 24 October 2019, the Company announced it had become necessary to issue and serve a claim in the English High Court against Ward Hadaway (the "UK Proceedings"), the solicitor acting for the Company at the time of the Contemplated Transaction, in order to fully protect the Company's rights pending the outcome of the US Proceedings.

 

· On 26 February 2021, Ward Hadaway were granted permission to join Foulston Siefkin LLP ("Foulston Siefkin"), Tanfield's US based law firm who were retained in 2013 to draft the documents governed by US law relating to the Contemplated Transaction, into the UK Proceedings. As a result, the Company amended its claim to include Foulston Siefkin as a second defendant.

 

 

Loan Subscription

 

Further to the update on 3 June 2021, in which the Company announced that the second loan note instrument (the "Second Loan") of up to £1m had subscriptions totalling £950,000, and the update on 30 March 2020, in which the Company announced the first loan note instrument (the "First Loan") of up to £700,000, with £500,000 initially being subscribed to, the Board is pleased to announce that an additional £125,000 of the First Loan has now been subscribed to, taking the total First Loan subscription value to £625,000. The additional First Loan (the "Additional Loan") will be used for providing ongoing funding for the US and UK Proceedings and other day to day costs.

 

The Additional Loan is unsecured and carries annual interest of 10% which is to accrue and is repayable on the earlier of (i) 28 February 2025 or (ii) receipt of sufficient funds relating to either the US or UK Proceedings. Should repayment take place prior to 28 February 2025, a 20% early redemption premium shall apply.

 

A number of existing shareholders have subscribed to the Additional Loan of £125,000, which constitutes a related party transaction under Rule 13 of the AIM Rules as a result of OTK Holding A/S and Zoar Invest Aps, which each hold approximately 14% of the issued shares of the Company, subscribing £50,000 each to the Additional Loan. The Directors of the Company, having consulted with WH Ireland Limited, the Company's nominated adviser, consider the terms of the transaction to be fair and reasonable in so far as shareholders are concerned.

 

Following discussions with the existing shareholders, the Board are of the opinion that further loan funding may be necessary to ensure that the Company can continue to protect its investment in Snorkel.

 

The Board believe that a positive outcome to either or both of the US Proceedings and UK Proceedings is a reasonable expectation, and the Company will continue to vigorously defend and advance its position in both proceedings, whilst continuing to seek advice. 

 

Further updates will be provided to Shareholders as and when appropriate.

 

 

 

For further information:

 

Tanfield Group Plc 020 7220 1666

Daryn Robinson  

 

WH Ireland Limited - Nominated Advisor / Broker

James Joyce / Ben Good 020 7220 1666

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKNBPBBKDNNK
Date   Source Headline
30th Dec 20084:40 pmRNSSecond Price Monitoring Extn
30th Dec 20084:37 pmRNSPrice Monitoring Extension
29th Dec 20084:41 pmRNSSecond Price Monitoring Extn
29th Dec 20084:37 pmRNSPrice Monitoring Extension
24th Dec 200812:41 pmRNSSecond Price Monitoring Extn
24th Dec 200812:36 pmRNSPrice Monitoring Extension
22nd Dec 20084:35 pmRNSPrice Monitoring Extension
1st Dec 20084:40 pmRNSSecond Price Monitoring Extn
1st Dec 20084:35 pmRNSPrice Monitoring Extension
18th Nov 20084:43 pmRNSSecond Price Monitoring Extn
18th Nov 20084:38 pmRNSPrice Monitoring Extension
11th Nov 20087:00 amRNSChange of Adviser
31st Oct 20084:51 pmRNSSecond Price Monitoring Extn
31st Oct 20084:40 pmRNSPrice Monitoring Extension
16th Oct 20084:39 pmRNSPrice Monitoring Extension
10th Oct 20084:45 pmRNSSecond Price Monitoring Extn
10th Oct 20084:44 pmRNSPrice Monitoring Extension
7th Oct 20087:00 amRNSDirector/PDMR Shareholding
6th Oct 20089:19 amRNSDirector/PDMR Shareholding
6th Oct 20089:17 amRNSDirector/PDMR Shareholding
2nd Oct 20088:57 amRNSDirector/PDMR Shareholding
1st Oct 20085:12 pmRNSHolding(s) in Company
1st Oct 20087:00 amRNSDirector/PDMR Shareholding
30th Sep 20087:00 amRNSInterim Results
17th Sep 20084:42 pmRNSSecond Price Monitoring Extn
17th Sep 20084:37 pmRNSPrice Monitoring Extension
27th Aug 20089:50 amRNSHolding(s) in Company
7th Aug 200810:22 amRNSHolding(s) in Company
18th Jul 20089:28 amRNSHolding(s) in Company
17th Jul 20083:21 pmRNSFurther re Director/PDMR Shar
16th Jul 20084:57 pmRNSHolding(s) in Company
16th Jul 20084:41 pmRNSDirector/PDMR Shareholding
15th Jul 20087:00 amRNSEnova Systems Comments on Tan
14th Jul 20083:33 pmRNSHolding(s) in Company
14th Jul 20087:00 amRNSHolding(s) in Company
10th Jul 20084:41 pmRNSSecond Price Monitoring Extn
10th Jul 20084:35 pmRNSPrice Monitoring Extension
9th Jul 20085:05 pmRNSDirector/PDMR Shareholding
8th Jul 20084:33 pmRNSDirector/PDMR Shareholding
8th Jul 20084:14 pmRNSHolding(s) in Company
8th Jul 200811:08 amRNSHolding(s) in Company
4th Jul 20086:28 pmRNSNew Bank Facility
1st Jul 20084:41 pmRNSSecond Price Monitoring Extn
1st Jul 20084:35 pmRNSPrice Monitoring Extension
1st Jul 200812:28 pmRNSHolding(s) in Company
1st Jul 20087:00 amRNSTrading Statement
27th Jun 200810:43 amRNSShare Price Movement
19th May 200810:06 amRNSHolding(s) in Company
13th May 20086:44 amRNSDetail of Order Book
29th Apr 20084:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.